{"cdcTestId":"2013-0208","testcaseName":"Recombivax Hep B ages 11-15.  Dose 2 recommended in 4-6 months. ","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on minimum interval from previous dose (catch-up)","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2010-03-29T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2023-02-19T00:00:00","recommendedDate":"2023-02-19T00:00:00","pastDueDate":"2023-06-15T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T15:24:07.367","generalDescription":"This test case describes when dose #1 of the Hep B Recombivax vaccine is administered at age 12 years, that dose #2 should be administered at 4 months - 6 months later.","changedInVersion":"1.0","reasonForChange":""}